Cutibacterium acnes surface and secreted antigens (C. acnes antigens)

Cutibacterium acnes surface and secreted antigens are a diverse group of proteins produced by the commensal bacterium C. acnes that drive the inflammatory pathology of acne vulgaris (PMID: 30111554). These antigens include Christie-Atkins-Munch-Petersen (CAMP) factors, lipases, sialidases, and adhesins, which facilitate bacterial colonization and tissue invasion (PMID: 21403631). Upon secretion, these molecules interact with host pattern recognition receptors, such as Toll-like receptor 2 (TLR2), leading to the activation of the NLRP3 inflammasome and the release of pro-inflammatory cytokines like IL-1β and IL-8 (PMID: 24659258). In particular, CAMP factor 2 has been identified as a major virulence factor that induces cell death in keratinocytes and macrophages (PMID: 30111554). Therapeutic strategies targeting these antigens include vaccines and monoclonal antibodies designed to neutralize their activity and reduce skin lesions (Sanofi, 2023). Unlike traditional antibiotics, these immunotherapies aim to specifically inhibit the pathogenic mechanisms of C. acnes without eradicating the entire population, thereby maintaining microbiome diversity. Clinical development of vaccines, such as SAR445351, focuses on generating long-term immunity against these secreted factors to prevent acne recurrence (ClinicalTrials.gov). Monitoring efficacy often involves measuring serum antibody titers against specific antigens and assessing the reduction in inflammatory lesion counts.

Other names

Propionibacterium acnes antigensC. acnes virulence factorsChristie-Atkins-Munch-Petersen factorsCAMP factorsSialidasesLipasesDermatan-sulfate adhesins

Neutralization of bacterial virulence factors and induction of antigen-specific humoral and cellular immunity to mitigate inflammatory responses.